MedTrace Logo

A Pharmacovigilance Study of Brain Oedema

NCT04311359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9524

Last updated 2020-03-17

No results posted yet for this study

Summary

Literature reports the development of brain oedema following the use of certain drugs. Therefore, this study aims to present a comprehensive disproportionality analysis of brain oedema cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS).

Conditions

  • Brain Edema
  • Brain Edema Caused by Drugs

Interventions

DRUG

Drugs, Generic

All drugs having 19 or more Brain Oedema cases reported to the FAERS database

Sponsors & Collaborators

  • University of Peshawar

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-20
Primary Completion
2019-11-10
Completion
2019-11-22
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04311359 on ClinicalTrials.gov